?
CHEETAH
2017 Cardiac Surgery
? ICUs
506 patients
Cardiac surgery & LV dysfn: levo vs placebo
Clinical Question
In patients undergoing cardiac surgery with left ventricular dysfunction,
does levosimendan compared to placebo reduce mortality?
Critical Appraisal
- Population
- Surgical Patients
- Population Details
- Preop LV dysfunction
- Intervention Arms
-
Levosimendan infusion
Levosimendan infusion - Control Arms
- Not recorded
- Primary Outcome
- 30 day mortality
- Secondary Outcomes
- Not recorded
- P Value
- 0.97
Outcome Results
Not recorded